NCRI 2019: Detecting ovarian cancer with CA125 blood test

A new study, the first of its kind, has looked at testing the levels of protein termed CA125 observed in the blood of women who are showing symptoms of ovarian cancer and the efficiency of the test in general practice. It has been determined that it may be a vital way to predict the chance of women developing ovarian cancer as well as being able to detect other types of cancers The results of the study are believed to potentially act as guides for patients and GPs on whether further testing is needing, and that clinical guidelines can be enhanced in...